Healthcare Industry
Global ImmunoDiagnostics Market 2009-2013DescriptionDescription:
25 February 2010, Pages - 18 Immunodiagnostics is a class of diagnostics tests that utilizes antigen-antibody reaction for the detection of diseases. The Clinical Diagnostics market is one of the fastest growing sectors of the healthcare industry. The advancement in various technologies ( biomolecular, genomic, etc) and the emergence of novel technologies are rapidly changing the diagnostics market. Further, the market has been witnessing greater importance in the emerging sectors like genetic testing which is poised to offer a potential growth for theragnostics and personalized medicine. These advancements offer Immunodiagnostics a tremendous potential to emerge as an important tool to develop high-sensitivity assays to improve the diagnosis and treatment of a wide range of diseases and disorders. The Immunodiagnostics market is characterized by technological innovation; thus delivering superior technology diagnostics test offerings. This advancement can be accounted to the emergence of different fields of medical sciences like proteomics, genomics, nucleic acid testing technology and nanobiotechnology. Such technological advancements continue to drive the innovation of new generation assays, biomarkers and innovative diagnostic tools. The different product offerings include test to identify pregnancies with risk for adverse outcomes, to identify prostate cancer, cardiac risk, etc. The report by TechNavio Insights forecasts the size of the worldwide Immunodiagnostics market over the period 2009-2013. Further, it discusses about the segmentation of the Immunodiagnostics market into various geographic regions. It also identifies the major market trends, drivers, and challenges existing for the same. Special Offer: You can request one free hour of analyst time when you purchase this report. Details provided within the report.
Table of ContentsTable of Contents:
1. Introduction 2. Immunodiagnostics Market Size & Forecast 3. Geographic Segmentation 3.1 Immunodiagnostics Market in Americas 3.2 Immunodiagnostics Market in EMEA 3.3 Immunodiagnostics Market in APAC 4. Market Trends of Immunodiagnostics 5. Drivers of Immunodiagnostics Market 6. Market Challenges for Immunodiagnostics 7. Immunodiagnostics Market Vendors 7.1 Abbott Laboratories 7.2 Beckman Coulter, Inc 7.3 Johnson & Johnson 7.4 Roche Holding AG 7.5 Siemens Healthcare Other Reports in this Series List of Exhibits Exhibit 2.1: Immunodiagnostics Market Size and Forecast 2009-2013 (In $ million) Exhibit 3.1: Immunodiagnostics Market Segmentation by Geography -2009 Exhibit 3.2: Americas Immunodiagnostics Market Size 2009-2013 (in $ million) Exhibit 3.3: EMEA Immunodiagnostics Market Size 2009-2013 (in $ million) Exhibit 3.4: APAC Immunodiagnostics Market Size 2009-2013 (in $ million) |
|
Global Neuromodulation Market 2009-2013DescriptionDescription:
24 February 2010, Pages - 19 Neuromodulation consist of devices, which are implantable, wireless controlled and delivers electrical current at targeted nerve fibers, to treat a patient's disabling neurological condition. It addresses the needs of the various neurological disorders, nervous system ailments and psychiatric illnesses. It is widely used for the treatment of chronic conditions such as lower back pain, urinary incontinence, Parkinson's disease, tremor, epilepsy, depression, etc. Advancement in technology and greater knowledge in neurophysiology offers vast potential opportunities in new treatments, leveraging tremendous growth of the Neuromodulation market. The Neuromodulation market is rapidly growing as it addresses a huge patient population in epilepsy, depression, stroke, anxiety disorders, Parkinson’s disease, etc. With this rapid growth, the market for Neuromodulation market is expected to become as large as the cardiac devices market. Further, the competition among the companies, emergence of new treatments, and the increasing patient population is expected to account for the growth of novel markets within the Neuromodulation field. In addition, the advances in technology and neuroscience pose potential opportunities for developing effective therapies for various neurological disorders. The report by TechNavio Insights forecasts the market size of the worldwide Neuromodulation market over the period 2009-2013. Further, the report discusses about the segmentation of the Neuromodulation market into various geographic regions. It also identifies the major market trends, drivers, and challenges existing for the Neuromodulation market. Special Offer: You can request one free hour of analyst time when you purchase this report. Details provided within the report.
Table of ContentsTable of Contents:
1. Introduction 2. Neuromodulation Market Size & Forecast 3. Geographic Segmentation 3.1 Neuromodulation Market in Americas 3.2 Neuromodulation Market in EMEA 3.3 Neuromodulation Market in APAC 4. Market Trends of Neuromodulation 5. Sales Drivers of Neuromodulation 6. Market Challenges for Neuromodulation 7. Neuromodulation Market Vendors 7.1 Boston Scientific Corporation 7.2 Cyberonics, Inc. 7.3 Johnson & Johnson 7.4 Medtronic, Inc 7.5 St. Jude Medical, Inc Other Reports in this Series List of Exhibits Exhibit 2.1: Neuromodulation Market Size and Forecast 2009-2013 (In $ million) Exhibit 3.1: Neuromodulation Market Segmentation by Geography -2009 Exhibit 3.2: Americas Neuromodulation Market Size 2009-2013 (in $ million) Exhibit 3.3: EMEA Neuromodulation Market Size 2009-2013 (in $ million) Exhibit 3.4: APAC Neuromodulation Market Size 2009-2013 (in $ million) |
|
Medical Devices Market in Latin America 2008-2012DescriptionDescription:
28 January 2010, Pages - 21 The Medical Devices market is introducing better therapies and solutions through the advancement in technology. The market holds a tremendous potential for devices offering minimal invasive treatment procedures, providing low cost diagnosis, monitoring and curing procedures with short recovery times. Further, the development of convergent products such as drug enhanced devices, next generation products (that enable organ regeneration) and advanced cellular therapy will offer potential opportunities within the market. The Latin American market is witnessing a growth; especially in countries such as Brazil, Mexico, etc. The expansion of the healthcare sector in these markets will offer expansion opportunities for the Medical devices. Further, countries like Argentina, Columbia, and Cuba also represent the developing medical devices market, which holds potential opportunities. However, Chile, Peru and Venezuela are still in their phase of development; and therefore, the market in these countries is highly dependent on imports from the US and Europe. The report by TechNavioTM Insights forecasts the size of the medical devices market in Latin America over the period 2008-2012. Further, it discusses the key market trends, drivers and challenges of the medical devices market in Latin America market and profiles some of the key vendors of this industry. Special Offer: You can request one free hour of analyst time when you purchase this report. Details provided within the report. Table of ContentsTable of Contents:
1. Introduction 2. Medical Devices in Latin America Market Size & Forecast 3. Geographic Segmentation 4. Market Trends of Medical Devices in Latin America 5. Growth Drivers of Medical Devices in the Latin America 6. Challenges for Medical Devices in Latin America 7. Major Medical Devices Vendors 7.1 Baxter International Inc 7.2 Boston Scientific Corporation 7.3 GE Healthcare 7.4 Johnson & Johnson 7.5 Medtronic, Inc 7.6 Baumer S.A 7.7 Biosensor Ind.Com.Ltda 7.8 Cmos Drake Do Nordeste Ltda 7.9 K.Takaoka Ind.Com.Ltda 7.10 XPRO Sistemas Ltda Other Vendors Other Reports in this Series List of Exhibits Exhibit 2.1: Latin America Medical Devices Market Size and Forecast 2008-2012 (In $ million) Exhibit 3.1: Latin America Medical Devices Market Segmentation by Geography -2008 |
|
Global Implantable Cardioverter Defibrillator (ICD) Market 2008-2012DescriptionDescription:
28 January 2010, Pages - 18 The ageing population, coupled with the increasing cases of cardiovascular diseases, and advancement in new innovative technologies, are driving the growth of Implantable Cardioverter Defibrillator (ICD) devices. ICDs are widely being used in Americas and Europe. Further, expansion of ICD therapies across the different Asian countries like China, Japan and India holds a potential growth for the ICD market. Consolidation of the industry through acquisitions and partnerships is also contributing to the growth of the ICD market in the industry. Over the past years, several large competitors have made significant acquisitions to fast-track technology into the market. The market for ICD shows a potential growth due to the increasing number of cardio vascular diseases (due to factors such as smoking, obesity, etc). The awareness of risk of developing cardiovascular problems and availability of the required treatment has enabled access to new technologies and quality products. This results in increase in the number of implants, and favorably influences the market growth. The report by TechNavioTM Insights forecasts the size of the global implantable cardioverter defibrillator (ICD)over the period 2008-2012. It segments the market into three geographic regions: Americas, APAC and EMEA, representing the market size and forecast for each of these regions. Further, it discusses the key market trends, drivers and challenges of the global implantable cardioverter defibrillator market and profiles some of the key vendors of this industry. Special Offer: You can request one free hour of analyst time when you purchase this report. Details provided within the report. Table of ContentsTable of Contents:
1. Introduction 2. Implantable Cardioverter Defibrillator (ICD) Market Size & Forecast 3. Market Segmentation by Geography 3.1 Implantable Cardioverter Defibrillator (ICD) Market in Americas 3.2 Implantable Cardioverter Defibrillator (ICD) Market in EMEA 3.3 Implantable Cardioverter Defibrillator (ICD) Market in APAC 4. Market Trends 5. Growth Drivers 6. Challenges for ICD Industry 7. Implantable Cardioverter Defibrillator (ICD) Vendors 7.1 BIOTRONIK, Inc 7.2 Boston Scientific Corporation 7.3 Medtronic, Inc 7.4 Sorin Group 7.5 St. Jude Medical Inc Other Reports in this Series List of Exhibits Exhibit 2.1: Global Implantable Cardioverter Defibrillator (ICD) Market Size and Forecast 2008-2012 (In $ million) Exhibit 3.1: Market Segmentation of Implantable Cardioverter Defibrillator (ICD) by Geography (2008) Exhibit 3.2: Americas Implantable Cardioverter Defibrillator (ICD) Market Size 2008-2012 (in $ million) Exhibit 3.3: EMEA Implantable Cardioverter Defibrillator (ICD) Market Size 2008-2012 (In $ million) Exhibit 3.4: APAC Implantable Cardioverter Defibrillator (ICD) Market Size 2008-2012 (in $ million) |
|
Global Drug Eluting Stent Market 2008-2012DescriptionDescription:
28 January 2010, Pages - 19 Drug Eluting Stents are used for the treatment of heart patients to prevent the need for more-invasive procedures, such as coronary artery bypass surgery. This reduces the need for repeated hospitalization and angioplasty procedures, thus reducing risks due to complications such as heart attack and stroke. The Global Drug Eluting Stent market has been registering a significant growth in the recent past. This market is witnessing a consolidation of major players through strategic alliances. Moreover, the Drug Eluting Stent providers are looking forward to expand their product portfolio to provide a full range of interventional therapies to the physicians and patients. The growth in the demand for the Drug Eluting Stent is due to its increasing acceptance as a viable treatment. Moreover, the growth is fueled by the robust economic growth and a greater adoption of social security schemes in the Asian regions. There are a large number of patients opting for these treatments so as to enhance their quality of life. Further, developed countries provide easy reimbursement options for higher-priced Drug Eluting Stent, which makes them affordable for patients. Moreover reimbursements by national medical savings schemes play a crucial role in the demand for the Drug Eluting Stents. The report by TechNavioTM Insights forecasts the drug eluting stents market size of the over the period 2008-2012. Further, it discusses the segmentation of the drug eluting stents market into various geographic regions. It also identifies the key market trends, drivers and challenges and profiles some of the key vendors of this market. Special Offer: You can request one free hour of analyst time when you purchase this report. Details provided within the report.
Table of ContentsTable of Contents:
1. Introduction 2. Global Drug Eluting Stent Market Size & Forecast 3. Geographic Segmentation 3.1 Drug Eluting Stent Market in Americas 3.2 Drug Eluting Stent Market in EMEA 3.3 Drug Eluting Stent Market in APAC 4. Market Trends of Global Drug Eluting Stent 5. Sales Drivers of Global Drug Eluting Stent 6. Market Challenges for Global Drug Eluting Stent 7. Market Vendors of Drug Eluting Stent 7.1 Abbott Laboratories 7.2 Biosensors International Group Limited 7.3 Boston Scientific 7.4 Johnson & Johnson 7.5 Medtronic, Inc. Other Drug Eluting Stent Providers Other Reports in this Series List of Exhibits Exhibit 2.1: Global Drug Eluting Stent Market Size and Forecast 2008-2012 (In $ million) Exhibit 3.1: Drug Eluting Stent Market Segmentation by Geography -2008 Exhibit 3.2: Americas Drug Eluting Stent Market Size 2008-2012 (in $ millions) Exhibit 3.3: EMEA Drug Eluting Stent Market Size 2008-2012 (in $ millions) Exhibit 3.4: APAC Drug Eluting Stent Market Size 2008-2012 (in $ millions) |
|
Global Cardiovascular Devices Market 2008-2012DescriptionDescription:
12 January 2010, Pages - 25 The cardiovascular devices represent one of the major markets in the medical equipment industry. This market consists of Cardiac Rhythm Management (CRM) devices, Interventional Cardiology (IC) devices, cardiovascular prosthetic devices, and cardiovascular surgery. With the advancement in technology, better therapies and solutions have been introduced into the healthcare market. Further, due to the intense competition, the players are driven to introduce new cardiovascular devices. Also, the manufacturers are emphasizing in next generation cardiovascular devices; with improved design, deliverability, and conformability. The development of next generation heart valves and drug eluting coronary stents, along with significant practices of biocompatible and bioabsorbable materials is expected to continue to drive innovation within the market. The ageing population, life saving benefits of cardiovascular devices, increasing patient base undergoing cardiac procedures, and growing health awareness are the key factors driving the growth of cardiovascular devices. Also, with the advancement in new innovative technologies, the companies are coming up with next generation devices, involving minimally invasive methods. Further, the significant practices of biocompatible and bioabsorbable materials in the cardiovascular devices will continue to drive innovation within the market. The report by TechNavioTM Insights forecasts the market size of the Global Cardiovascular Devices market for 2008-2012. Further, the report discusses about the segmentation of the Global Cardiovascular Devices market into various geographic regions. It also identifies the major market trends, drivers, and challenges existing for the Global Cardiovascular Devices market and profiles the key vendors of this industry. Special Offer: You can request one free hour of analyst time when you purchase this report. Details provided within the report. Table of ContentsTable of Contents:
1. Introduction 2. Global Cardiovascular Devices Market Size & Forecast 3. Market Segmentation by Geography 3.1 Cardiovascular Devices Market in Americas 3.2 Cardiovascular Devices Market in EMEA 3.3 Cardiovascular Devices Market in APAC 4. Market Trends 5. Growth Drivers 6. Challenges for Cardiovascular Devices Industry 7. Cardiovascular Devices Vendors 7.1 Abbott Laboratories 7.2 ATS Medical, Inc 7.3 BIOTRONIK, Inc 7.4 Boston Scientific Corporation 7.5 CR Bard Inc 7.6 Edwards Lifesciences Corporation 7.7 Johnson & Johnson 7.8 Medtronic, Inc 7.9 Sorin Group 7.10 St. Jude Medical Inc Other Reports in this Series List of Exhibits Exhibit 2.1: Global Cardiovascular Devices Market Size and Forecast 2008-2012 (In $ million) Exhibit 3.1: Market Segmentation of Global Cardiovascular Devices by Geography (2008) Exhibit 3.2: Americas Cardiovascular Devices Market Size 2008-2012 (in $ million) Exhibit 3.3: EMEA Cardiovascular Devices Market Size 2008-2012 (In $ million) Exhibit 3.4: APAC Cardiovascular Devices Market Size 2008-2012 (in $ million) |
|
Medical Devices Market in Europe 2008-2012DescriptionDescription:
12 January 2010, Pages - 22 Medical devices are those products that are used for medical examination, surgery or treatment of patients. These devices include surgical, diagnostic & imaging, ophthalmic, laboratory, and dental instruments. In addition, the X-ray apparatus, medical supplies (such as bandages), and disposables such as syringes, needles and catheters also come under this category. The Medical devices market in Europe is introducing better therapies and solutions through the advancement in technology. Further, the competition in the market is leading the manufacturers to introduce new devices. The market holds tremendous potential for the devices offering minimal invasive treatment procedures, providing low cost diagnosis, monitoring and curing procedures with short recovery times. The increased need for Medical devices in Europe can be accounted to the growth in the aging population. The population aged above 65 is these more health conscious and is attending regular health checkups. Further, with more number of people getting aware of new technologies, more information through medical diagnosis is expected. The report by TechNavioTM Insights forecasts the market size of the Medical Devices Market in Europe for 2008-2012. It also discusses the market trends, drivers and challenges of the industry in the European market and profiles the key vendors in this industry. Special Offer: You can request one free hour of analyst time when you purchase this report. Details provided within the report.
Table of ContentsTable of Contents:
1. Introduction 2. European Medical Device Market Size & Forecast 2.1 European Medical Device Market Segmentation 3. European Medical Devices Market Trends 4. European Medical Devices Growth Drivers 5. European Medical Devices Challenges 6. Medical Devices Vendors 6.1 Baxter International Inc. 6.2 Boston Scientific Corporation 6.3 Johnson and Johnson 6.4 Medtronic, Inc 6.5 St. Jude Medical Inc 6.6 B. Braun Melsungen AG 6.7 GE Healthcare 6.8 Siemens Healthcare 6.9 Smith & Nephew Plc 6.10 Philips Healthcare Other Reports in this Series List of Exhibits Exhibit 2.1: European Medical Device Market Size & Forecast 2008-2012 (In $billion) Exhibit 2.2: European Medical Device Market Segmentation - 2008 |
|
Dialysis Products Market in United States 2008-2012DescriptionDescription:
12 January 2010, Pages - 18 End-stage renal disease (ESRD) is an irreversible loss of kidney function, which requires treatment with dialysis or transplantation. The treatment, through dialysis, includes artificial means for removal of toxins and excess fluids from the bloodstream. The dialysis process is of two different types: Hemodialysis and Peritoneal Dialysis. The products used for Hemodialysis comprises hemodialysis machines, home-use machines, blood lines, dialyzers, catheter access, AV fistulae access, etc. The products used for Peritoneal dialysis comprises peritoneal dialysis machines and peritoneal transfer sets. The number of Dialysis patients is growing in the US with the changing demographic patterns. According to the United States Renal Data System (USRDS) estimates, the prevalence of renal failure cases is high, especially in the developed countries. The main cause for this can be attributed to the dietary habits of the people. Moreover, the number of people willing to donate their kidneys for transplantation to the ESRD patients is very less. Thus, the Dialysis products market in the US is witnessing an increase in the number of patients suffering from chronic kidney failure. The report by TechNavioTM Insights discusses the various aspects of the Dialysis products in the US. It forecasts the market size of the products used for Dialysis in the US over the period 2008-2012. Further, the report also provides segmentation of the Dialysis products in the US market. It also identifies the major market trends, drivers, and challenges existing for the Dialysis products in the US. Special Offer: You can request one free hour of analyst time when you purchase this report. Details provided within the report.
Table of ContentsTable of Contents:
1. Introduction 2. Dialysis products in the US Market Size & Forecast 2.1 Dialysis Patients in the US Market 3. Product Segmentation 4. Market Trends of Dialysis products in the US 5. Sales Drivers of Dialysis products in the US 6. Market Challenges for Dialysis products in the US 7. Market Vendors for Dialysis products in the US 7.1 Aksys Ltd. 7.2 Baxter Healthcare Corporation 7.3 Fresenius Medical Care North America 7.4 NxStage Medical, Inc. 7.5 Rockwell Medical Technologies, Inc. 7.6 Teleflex Medical, Inc. Other Dialysis Providers in the US Market Other Reports in this Series List of Exhibits Exhibit 2.1: Dialysis products in the US Market Size and Forecast 2008-2012 (In $ million) Exhibit 2.2: Dialysis Patients in the US- 2008-2012 Exhibit 3.1: Dialysis Product Segmentation in the US Market -2008
|
|
Global Cardiac Rhythm Management (CRM) Market 2008-2012DescriptionDescription:
11 December 2009, Pages - 18 Cardiac Rhythm Management (CRM) is a field of treatment in cardiology. It involves various therapies in administering cardiac arrhythmias (abnormal electrical activity in the heart). CRM majorly consists of devices such as Implantable Cardioverter Defibrillators (ICD), implantable pacemakers, and other CRM monitoring devices. In early 2000’s, the CRM market experienced several product warnings and recalls, pertaining to quality concerns. This resulted in decreased utilization of the CRM devices. However, life-saving benefits of CRM devices and development of high quality, feature-packed CRM devices have helped the market return to a positive growth in 2007. Further, a steady growth of the CRM market is expected over the next few years; owing to the favorable drivers and increasing expansion of CRM therapies across different Asian countries (like Japan, India and China). The ageing population, coupled with the increasing number of cardiovascular diseases and advancement in new innovative technologies, is driving the growth of cardiac rhythm management devices. Consolidation of the industry through acquisitions and partnerships is also contributing to the growth of the Cardiac Rhythm Management market. Over the last few years, several large competitors have made significant acquisitions to fast-track technology into the market. For instance: Boston Scientific acquired Guidant, St. Jude acquired Advanced Neuromodulation Systems Inc. and Radi Medical Systems. The companies pursue new technologies and strengthen their R&D activities through these acquisitions. The report by TechNavioTM Insights forecasts the market size of the Global Cardiac Rhythm Management (CRM) market over the period 2008-2012. Further, the report discusses the segmentation of the total Cardiac Rhythm Management (CRM) market into various geographic regions. It also identifies the major market trends, drivers, and challenges existing for the Global Cardiac Rhythm Management (CRM) market, and profiles some of the key vendors of this market. Special Offer: You can request one free hour of analyst time when you purchase this report. Details provided within the report. Table of ContentsTable of Contents:
1. Introduction 2. Cardiac Rhythm Management (CRM) Market Size & Forecast 3. Market Segmentation by Geography 3.1 Cardiac Rhythm Management (CRM) Market in Americas 3.2 Cardiac Rhythm Management (CRM) Market in EMEA 3.3 Cardiac Rhythm Management (CRM) Market in APAC 4. Market Trends 5. Growth Drivers 6. Challenges for the CRM Industry 7. Cardiac Rhythm Management (CRM) Vendors 7.1 BIOTRONIK, Inc 7.2 Boston Scientific Corporation 7.3 Medtronic, Inc 7.4 Sorin Group 7.5 St. Jude Medical Inc Other Reports in this Series List of Exhibits Exhibit 2.1: Global Cardiac Rhythm Management (CRM) Market Size and Forecast 2008-2012 (In $ million) Exhibit 3.1: Market Segmentation of Cardiac Rhythm Management (CRM) by Geography (2008) Exhibit 3.2: Americas Cardiac Rhythm Management (CRM) Market Size 2008-2012 (in $ million) Exhibit 3.3: EMEA Cardiac Rhythm Management (CRM) Market Size 2008-2012 (In $ million) Exhibit 3.4: Cardiac Rhythm Management (CRM) Market Size 2008-2012 (in $ million) |
|
Global Server Hardware Market in Healthcare Industry 2008-2012DescriptionDescription:
17 November 2009, Pages - 20 Server hardware includes various types of servers and associated hardware. Examples of server hardware include blades, fault-tolerant servers, mainframes, x86S-Standard servers, parallel processors, supercomputers, RISC based servers, messaging servers, etc. At present, the primary concern of enterprises is hardware obsolescence due to advancements in technology. The increasing downtime due to older hardware has hampered the businesses severely; thus productivity from such hardware has become a paramount issue. Also, running older hardware for a longer period of time is cost expensive; resulting in a need of energy efficient hardware. With the increase of patient load for various healthcare service providers, the need to store and manage the entire patient-related information is also increasing. This is leading to an increased demand for server hardware in the healthcare industry. The healthcare industry comprises healthcare service providers, medical device manufacturers, pharmaceutical companies, and health insurance firms. Increasing healthcare cost, expanding market demand, and increasing awareness among consumers is expected to characterize the healthcare industry in the near future. The demand of healthcare facilities is increasing owing to increased growth of aging population, increasing number of chronic patients, rising healthcare consumerism, increasing awareness and rise in income level of users. However, the supply is constrained with limited financial resources, shortage skilled manpower, and outdated facilities. The server hardware market is witnessing an increase in the demand for environment-friendly servers, which are developed from eco-friendly and recycling materials, and features power management tools. Through these servers, companies are exploring new ways to have a green image. Further, vendors are focusing on bringing out server hardware that has a green tag so as to meet the legislative mandates on component materials, building guidelines, etc. The report by TechNavio Insights forecasts the size of the global server hardware market in healthcare industry over the period 2008-2012. It segments the server hardware market into various geographic regions (representing the market size for each of these regions). Further, it discusses the key market trends, drivers and challenges of the server hardware market in the healthcare industry, and profiles some of the key vendors of this industry. Special Offer: You can request one free hour of analyst time when you purchase this report. Details provided within the report. Table of ContentsTable of Contents:
1. Introduction 2. Market Size & Forecast 3. Geographic Segmentation 3.1 Server Hardware Market in Healthcare Industry in Americas 3.2 Server Hardware Market in Healthcare Industry in APAC 3.3 Server Hardware Market in Healthcare Industry in EMEA 4. Trends 5. Drivers 6. Challenges 7. Vendors 7.1 Dell Inc. 7.2 Fujitsu 7.3 Hewlett Packard (HP) 7.4 IBM 7.5 ORACLE Other Reports in this Series List of Exhibits Exhibit 2.1: Server Hardware Market in Healthcare Industry Market Size and Forecast 2008-2012 (In $ million) Exhibit 3.1: Server Hardware Market in Healthcare Industry Segmentation by Geography – 2008 Exhibit 3.2: Americas System and Server Hardware Market in Healthcare Industry Size 2008-2012 (in $ million) Exhibit 3.3: APAC System and Server Hardware Market in Healthcare Industry Size 2008-2012 (in $ million) Exhibit 3.4: EMEA System and Server Hardware Market in Healthcare Industry Size 2008-2012 (In $ million) |
|